论文部分内容阅读
目的探讨妈富隆在宫腔镜子宫内膜息肉切除术(TCRP)后应用的临床价值。方法将我院2010年3月至2011年3月收治的82例子宫内膜息肉患者分为两组:观察组和对照组,两组均行宫腔镜子宫内膜息肉电切术,观察组术后给予妈富隆治疗3个月,对照组术后给予甲羟孕酮治疗3个月,将两组术后阴道出血时间、子宫内膜复发情况做对比。结果妈富隆组术后阴道出血时间短、子宫内膜息肉复发率低,对照组术后阴道出血时间长、复发率高。结论妈富隆应用于TCRP术后治疗效果好,复发率低。
Objective To investigate the clinical value of Marvelon applied after hysteroscopic endometrial polypectomy (TCRP). Methods 82 patients with endometrial polyps treated in our hospital from March 2010 to March 2011 were divided into two groups: observation group and control group. Hysteroscopic endometrial polyps resection was performed in both groups. The observation group After giving Marvelon treatment for 3 months, control group after giving medroxyprogesterone acetate for 3 months, the two groups of postoperative vaginal bleeding time, endometrial recurrence compared. Results Marvelon group postoperative vaginal bleeding time is short, the recurrence rate of endometrial polyps low, the control group postoperative vaginal bleeding for a long time, the recurrence rate. Conclusion Marvelon is effective in treating postoperative TCRP with low recurrence rate.